Cartesian Therapeutics, Inc.·4

Jan 6, 4:18 PM ET

SPRINGER TIMOTHY A 4

4 · Cartesian Therapeutics, Inc. · Filed Jan 6, 2026

Insider Transaction Report

Form 4
Period: 2026-01-02
SPRINGER TIMOTHY A
Director10% Owner
Transactions
  • Award

    Common Stock

    2026-01-02+2,6008,646,285 total
  • Award

    Stock Option (Right to Buy)

    2026-01-02+7,8007,800 total
    Exercise: $6.76From: 2027-01-02Exp: 2036-01-01Common Stock (7,800 underlying)
Holdings
  • Common Stock

    (indirect: By Spouse)
    330,695
  • Common Stock

    (indirect: See Footnote)
    656,513
Footnotes (2)
  • [F1]Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in full on January 2, 2027.
  • [F2]Held by TAS Partners LLC. The reporting person is the managing member of TAS Partners LLC. The reporting person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any.

Documents

1 file
  • 4
    wk-form4_1767734290.xmlPrimary

    FORM 4